Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis-Solid Tumors

Discrepancy between CT & PET in evaluating treatment response (ETR) & follow-up (FU) in patients (pts) with soft tissue sarcomas (STS)

Elena Piperkova, Mounir Mikhaeil, Richard Libes, Ali Mosavi, Francisco Viejo-Rullan, Henry Lin, Gerald Rosen and Hussein Abdel-Dayem
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 190P;
Elena Piperkova
1Nuclear Medicine, St. Vincent's Hospital & Medical Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mounir Mikhaeil
1Nuclear Medicine, St. Vincent's Hospital & Medical Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Libes
2Oncology, St. Vincent's Comprehensive Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Mosavi
1Nuclear Medicine, St. Vincent's Hospital & Medical Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Viejo-Rullan
1Nuclear Medicine, St. Vincent's Hospital & Medical Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Lin
1Nuclear Medicine, St. Vincent's Hospital & Medical Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald Rosen
2Oncology, St. Vincent's Comprehensive Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hussein Abdel-Dayem
1Nuclear Medicine, St. Vincent's Hospital & Medical Center, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

648

Objectives: STS are rare mesenchymal tumors with a wide array of histologic subtypes & biologic behavior which contribute to difficulty in predicting natural history & patterns of treatment response. To evaluate impact of both F-18 FDG PET & low dose CT components in PET/CT studies (std) performed for initial staging (I.S.), ETR post-surgery, radio or chemotherapy, short & long range FU & restaging in pts with STS, & focus on discrepancy between CT & PET findings. Methods: 58 pts with STS underwent 111 std: 7 I.S., 43 ETR up to 2 months(mo), 27 early FU from 2-6 mo & 34 long-term FU (>6 mo) were included. Histologic subtypes: 16 lipo, 21 leiomyo, 6 rhabdomyo, 3 synovial , 4 fibro, 3 hemangio, 1 chondro, 1 Schwanona, 1 GIST, 1 neuroectodermal sarcomas & 1 metastatic STS from unknown primary. All underwent PET/CT between 60-90 min following 10-15 mCi of 18F-FDG on GE Discovery PET/CT. Oral contrast was given. Findings were confirmed by clinical FU. Studies read by Nuclear Medicine & Radiology specialists. Results: 264 lesions detected, 235 concordant between PET & CT portions of PET/CT & 2911%) discordant. I.S. (7 std) CT & PET concordant in 5 & discordant in 2. ETR (43 std) PET/CT concordant in 35 (24 complete, 1 partial response(resp), 2 no resp, 3 progression & 5 mixed resp). Discordance found in 8(19%) (5 complete & 2 partial resp in PET & no change on corresponding CT, 1 study PET showed partial resp vs no changes on CT). PET identified bone marrow hyperplasia in 4 std before end of first mo after therapy. 27 std performed for early FU (2-6 mo) were concordant in 23 (complete resp 8, partial 2, progression 9 & mixed resp 4). Discordance observed in 4 std(15%) (1 complete resp, 2 partial resp in PET vs CT showing no resp in these 3 & 1 partial resp on PET vs CT progression of dx). 34 std for long term FU showed concordance in 30 std (11 free of dx, 3 stable & 16 recurrence or progression). Discordance was seen in 4(12%) (3 PET negative vs CT recurrence & 1 PET positive vs CT free of dx). Conclusions: In ETR, either short or long term FU, although combined PET/CT had higher accuracy than either alone, FDG PET is more accurate than CT alone.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Discrepancy between CT & PET in evaluating treatment response (ETR) & follow-up (FU) in patients (pts) with soft tissue sarcomas (STS)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Discrepancy between CT & PET in evaluating treatment response (ETR) & follow-up (FU) in patients (pts) with soft tissue sarcomas (STS)
Elena Piperkova, Mounir Mikhaeil, Richard Libes, Ali Mosavi, Francisco Viejo-Rullan, Henry Lin, Gerald Rosen, Hussein Abdel-Dayem
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 190P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Discrepancy between CT & PET in evaluating treatment response (ETR) & follow-up (FU) in patients (pts) with soft tissue sarcomas (STS)
Elena Piperkova, Mounir Mikhaeil, Richard Libes, Ali Mosavi, Francisco Viejo-Rullan, Henry Lin, Gerald Rosen, Hussein Abdel-Dayem
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 190P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis-Solid Tumors

  • Differential diagnosis of endometrial hyperplasia and cancer using combined 18F-FES and 18F-FDG PET
  • Initial FDG uptake in patients with adenocarcinomas of the esophagogastric junction (AEG): Is it correlated to tumor localization and to patients' survival?
  • Role of FDG-PET in the diagnosis of recurrent and metastatic lesions of malignant testicular tumors
Show more Oncology: Clinical Diagnosis-Solid Tumors

Sarcoma/Melanoma

  • Prospective comparison of 18F-FDG PET/CT and conventional modalities for staging of Ewing sarcoma family of tumours
  • The prognostic value of 18F-FDG PET/CT in postoperative recurrence of retroperitoneal liposarcoma: a single center retrospective study
  • Restaging Malignant Melanoma with 18F-FDG PET/CT metabolic parameters to predict overall survival
Show more Sarcoma/Melanoma

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire